Fundamental dimension Equity attribute | ARKRPeer $4.48▲+0.74% Cap $16.15MP/E -5.1x QuantScore25/100 | AZIPeer $0.7988▼-2.35% Cap $3.59MP/E -0.1x QuantScore21/100 | BGILeader $0.35▼-6.47% Cap $4.20MP/E -2.8x QuantScore38/100 |
|---|---|---|---|
1. QuantScore pillars0–100 per pillar · click a ticker for the factor breakdown | |||
Technical Trend, RSI, MACD & signal consensus | |||
61/100 |
23/100 |
49/100 |
Valuation Multiples, PEG & DCF upside | 33/100 | 33/100 | 25/100 |
Health Piotroski, Altman Z, leverage & liquidity | 0/100 | 27/100 | 28/100 |
Growth Revenue / earnings growth & margins | 4/100 | 2/100 | 51/100 |
Sentiment Analyst ratings, targets & revisions | — | — | — |
2. Valuation multiples & capital pricingGreen highlight = best-in-class (lowest positive multiple) |
Trailing P/E | -5.1x | -0.1x | -2.8x |
Forward P/E (next FY) | — | — | — |
EV / EBITDA (TTM) | 236.7x | -0.9x | 15.8x |
Price / Sales | 0.1x | 0.0x | 0.0x |
Price / Free Cash Flow | -2.6x | -21.3x | -2.7x |
PEG ratio | -0.04 | 0.00 | -0.04 |
3. Financial health & solvencyLatest filings |
Piotroski F-Score | 2 / 9 | 3 / 9 | 4 / 9 |
Altman Z-Score | 1.40 (Distress) | -4.06 (Distress) | 0.01 (Distress) |
Total debt / equity | 2.66 | -2.22 | -7.75 |
Quick ratio | 0.7x | 1.1x | 0.1x |
Interest coverage | -7.6x | -15.6x | 0.4x |
4. Growth & margins trajectoryLatest fiscal year |
Revenue growth YoY | -9.7% | -1.6% | +16.6% |
Net income growth YoY | -194.3% | -52.1% | +73.3% |
Gross margin (TTM) | 28.3% | 1.4% | 35.0% |
Operating margin (FY) | -0.8% | -14.3% | 1.6% |
FCF margin (FY) | -0.9% | -3.8% | -1.3% |
5. Trailing price performancePrice change over period |
1M return | -0.7% | -31.7% | -6.5% |
3M return | -24.6% | -31.1% | -39.6% |
6M return | -34.2% | -39.9% | -52.7% |
Year to date | -33.3% | -97.4% | -61.1% |
1Y return | -36.6% | -98.5% | -69.8% |
3Y return | -70.5% | -99.9% | -92.1% |
6. DCF valuation & street consensusDCF model · analyst consensus |
DCF model fair value | $29.81 +565.7% upside | $-50.85 -6466.3% premium | $-10.81 -3187.4% premium |
Wall Street consensus target | — — | — — | — — |
Consensus stance | — | — | — |